logo

Biotechnology & Drugs News

Share

AstraZeneca Says Orpathys Approved In China For Lung Cancer And MET Gene Alterations

Santhera Pharma Announces Positive Topline Results From Long-term Phase 4 LEROS S Tudy With Raxone

Histogen, Amerimmune Report Positive Top-Line Study Results From Phase 1 Study Of Emricasan

TFF, Augmenta Bioworks Select AUG-3387 For Clinical Development Against COVID-19